2021 – Medigus

23, December 2021

Polyrizon to Test its Product Candidate for Protection Against the Highly Transmissible Corona Virus Omicron Variant

In recent pre-clinical studies, Polyrizon products demonstrated a great potential in preventing human coronavirus 229E and Influenza Virus H1N1

14, December 2021

Medigus Filed a $3 Million Buyback Program

increasing the contemplated program from $2 million to $3 million

14, December 2021

Medigus: Jeffs’ Brands Submitted Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

20, October 2021

Medigus: Eventer and Safee Will Enable Artists and Producers to Create and Sell NFTs

Eventer will enable its customers to originate, monetize and sell digital assets through Safee's NFT-based social network platform

19, October 2021

Medigus Enters NFT Space with a First Investment in Blockchain Company Safee

Medigus to invest $400,000 in Safee, an NFT-based ownership social network aiming to bring its unique technology to mass market creators and audiences

20, September 2021

MEDIGUS LTD. ANNOUNCES RECORD HIGH FINANCIAL RESULTS

Medigus Ltd. announced today its financial results for the first six months ended June 30, 2021.

13, September 2021

Medigus: Revoltz commenced prototype manufacturing of its micro-mobility vehicle

Revoltz Model One is a micro-mobility vehicle for last mile and food delivery.

17, August 2021

Medigus: Jeffs’ Brands Ltd.

signed a Non-binding Loi to Acquire a Leading Consumer Products Brand Company

30, July 2021

Medigus: Charging Robotics Successfully Completes a Proof of Concept

for its Electric Vehicle Wireless Charging Robot

26, July 2021

Medigus Board of Directors

decides to Promote a $2 Million Buyback Program

Newscat: 2021